日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Luteolin ameliorates steroid-induced osteonecrosis of the femoral head via a gut microbiota-L-Carnitine-IFIH1 axis.

木犀草素通过肠道菌群-左旋肉碱-IFIH1轴改善类固醇引起的股骨头坏死。

Li Tong, Li Yifei, Gao Jiaxiang, Ma Ruichen, Peng Yue, Zhang Qidong, Chen Yingzhi, Wang Weiguo

Anifrolumab to Treat Severe Hepatic Involvement in a De Novo IFIH1 Mutation

阿尼弗鲁单抗用于治疗新生 IFIH1 突变引起的严重肝脏受累

Romano, Micol; Demirkaya, Erkan; Zizzo, Andréanne N; Berard, Roberta A

How loss-of-function mutations in IFIH1 contribute to infectious and/or inflammatory disease - a systematic review

IFIH1功能缺失突变如何导致感染性和/或炎症性疾病——系统性综述

Ince, Isabelle; Sposito, Francesca; Charras, Amandine; McCann, Liza J; Hedrich, Christian M

Repeated Episodes of GPP Induced by Respiratory Infections Are Mediated by Loss-of-Function IFIH1

呼吸道感染诱发的反复发作的GPP是由IFIH1功能丧失介导的。

Liu, Yaqin; Sun, Yanan; Yang, Juan; Li, Hongmei; Zhou, Weihui; Meng, Shasha

Light-Induced, Lysine-Targeting Irreversible Covalent Inhibition of the Human Oxygen Sensing Hydroxylase Factor Inhibiting HIF (FIH)

光诱导的赖氨酸靶向不可逆共价抑制人氧感应羟化酶因子HIF(FIH)

Wu, Yue; Li, Zhihong; Kaur, Samanpreet; Zhang, Zewei; Yue, Jie; Tumber, Anthony; Zhang, Haoshu; Song, Zhe; Yang, Peiyao; Dong, Ying; Yang, Fulai; Li, Xiang; Schofield, Christopher J; Zhang, Xiaojin

Corrigendum: FIH-1: a novel protein that interacts with HIF-1α and VHL to mediate repression of HIF-1 transcriptional activity

更正:FIH-1:一种与HIF-1α和VHL相互作用以介导HIF-1转录活性抑制的新型蛋白质

Mahon, Patrick C; Hirota, Kiichi; Semenza, Gregg L

Stage-specific antiviral roles of IFIH1, IRF7, and MAVS in the interferon-mediated response to DHAV-3 infection.

IFIH1、IRF7 和 MAVS 在干扰素介导的 DHAV-3 感染反应中发挥阶段特异性抗病毒作用。

Li Huihui, Tang Yi, Hou Shuisheng, Liang Suyun

Cellular and functional insights into FIH-mediated hydroxylation of TRPA1

FIH介导的TRPA1羟基化的细胞和功能研究

Guo, Tao; Lopez, Dianne Marquez; Wang, Siyuan; Yao, Liudi; Li, Xi; Davies, Elizabeth R; Vargas-Caballero, Mariana; Divecha, Nullin; Schofield, Christopher J; Deinhardt, Katrin; Wang, Yihua

An Anti-tau Therapeutic Antibody Etalanetug (E2814): A Phase 1, First-in-human (FIH) Study of Single and Multiple Ascending Doses in Healthy Subjects

抗tau治疗性抗体Etalanetug(E2814):一项针对健康受试者的单次和多次递增剂量I期首次人体(FIH)研究

Rawal, Sumit; Wildsmith, Kristin R; Aluri, Jagadeesh; Yagi, Takuya; Chang, Min-Kun; Niu, Hongmei; Zhou, Jin; Horie, Kanta; Takahashi, Eri; Boyd, Peter; Reyderman, Larisa

Correction to "Diagnostic Odyssey and Full Mouth Rehabilitation of a Juvenile Patient With IFIH1-Related Disorder: A Case of Aicardi-Goutières and Singleton Merten Syndromes Overlap"

对“一名患有 IFIH1 相关疾病的青少年患者的诊断历程和全口康复:Aicardi-Goutières 综合征和 Singleton Merten 综合征重叠病例”的更正